drugset / Trial / NCT00440518
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this study is to see how safe and effective Lacosamide (LCM) is when taken by mouth, twice a day for up to 18 weeks to prevent migraines.
Timeline
- Start
- 2007-02
- Primary completion
- 2008-07
- Completion
- 2008-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lacosamide | Other / unclassified | 100 mg | Oral |
| Subject | Lacosamide | Other / unclassified | 300 mg | Oral |